2 completed. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 2 |
Follow Ischemic Cardiomyopathy: new trials by email Literature Review of Ischemic Cardiomyopathy trials Research Report on Ischemic Cardiomyopathy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Ranolazine Implantable Cardioverter-Defibrillator Trial Ranolazine - Ischemic Cardiomyopathy, Nonischemic Cardiomyopathy | Phase 3 | Completed | University of Rochester | 1012 | 2011-09-01 | 2018-08-27 |
| Study to Compare TWA Test and EPS Test for Predicting Patients at Risk for Life-threatening Heart Rhythms (ABCD Study) T-Wave Alternans test - Ischemic Cardiomyopathy, LV Dysfunction | Phase 3 | Completed | Abbott Medical Devices | 618 | 2001-04-01 | 2023-07-13 |
Death, Sudden (1) · Heart Failure (1) · Tachycardia, Ventricular (1) · Ventricular Dysfunction, Left (1) · Ventricular Fibrillation (1)
Cardiovascular Diseases (2) · Heart Diseases (2) · Arrhythmias, Cardiac (1) · Cardiac Conduction System Disease (1) · Death (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Tachycardia (1) · Ventricular Dysfunction (1)
Ranolazine (1)
Abbott Medical Devices (1) · University of Rochester (1)
Canada (1) · United States (1)
David Rosenbaum, MD (1) · Otto Costantini, MD (1) · Wojciech Zareba, MD PhD (1)